$57.7 Million
Alphatec Holdings, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$40.0 Million
XBiotech, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$63.3 Million
Fluidigm Corporation
Follow-On Offering
Left Bookrunner
$46.0 Million
Eiger BioPharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$38.0 Million
Novan, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$37.4 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$57.5 Million
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$250.0 Million
Prothena Corporation plc
At the Market Offering
Left Bookrunner
$45.0 Million
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
$125.0 Million
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
Subscribe to Left Bookrunner

© 2026 Piper Sandler Companies. Since 1895. All rights reserved.